NCT07650331

Brief Summary

Background and Objective: Stroke frequently impairs gait functionality, leading to significant limitations in functional independence and quality of life. Objective gait analysis is essential for evaluating clinical status and rehabilitation progress. While laboratory-bound, non-wearable systems are considered the gold standard, their high cost, complex infrastructure, and requirement for specialized personnel limit their routine implementation in daily clinical practice. Portable inertial measurement units have emerged as a practical, low-cost alternative for motion analysis outside traditional laboratory settings. However, evidence regarding specific commercial devices in pathological populations remains limited. This study aims to evaluate the inter-rater and intra-rater reliability of the commercially available Baiobit® lumbar-mounted inertial sensor for measuring spatiotemporal gait parameters in stroke survivors. Methodology: A prospective, single-group, repeated-measures design was conducted at a specialized neurorehabilitation clinic (Neuron Clinic, Madrid). A convenience sample of 22 adults diagnosed with subacute or chronic stroke who were able to ambulate independently was included. Gait assessments were performed by two trained evaluators across two separate sessions spaced 24 to 48 hours apart. During each session, the Baiobit® sensor was secured to the participants' sacral region (S1-S2) using an adjustable belt. Participants performed three 10-meter walking trials at their comfortable, self-selected pace for each evaluator. Reliability was quantified using Intraclass Correlation Coefficients (ICC), Standard Error of Measurement (SEM), and Minimal Detectable Change (MDC). Expected Outcomes: It is hypothesized that the Baiobit® inertial sensor will demonstrate adequate relative and absolute inter- and intra-rater reliability across spatiotemporal gait parameters, supporting its viability as an objective monitoring tool in routine stroke rehabilitation clinical settings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 10, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2026

Completed
24 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 14, 2026

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

June 10, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 16, 2026

Completed
Last Updated

June 16, 2026

Status Verified

June 1, 2026

Enrollment Period

6 months

First QC Date

June 10, 2026

Last Update Submit

June 10, 2026

Conditions

Keywords

StrokeGait rehabilitationInertial measurement unitsValidation

Outcome Measures

Primary Outcomes (1)

  • Intra-rater reliability of spatiotemporal gait parameters

    Relative and absolute consistency of spatiotemporal gait metrics derived from repeated measurements taken by the same evaluator

    Up to 48 hours

Secondary Outcomes (1)

  • Inter-rater reliability of spatiotemporal gait parameters

    Day 1 and day 2

Study Arms (1)

Participants

All the participants included

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of a convenience sample of adult stroke survivors receiving outpatient physical therapy and neurorehabilitation care. Participants include individuals with a confirmed diagnosis of either ischemic or hemorrhagic stroke, in both subacute and chronic stages (time since onset greater than one month), who retain the functional capacity to ambulate independently on overground surfaces without physical assistance. All participants are recruited from the outpatient facilities of a specialized neurorehabilitation center (Neuron Clinics) located in Madrid, Spain.

You may qualify if:

  • adults aged 18-85 years
  • confirmed diagnosis of stroke
  • ability to ambulate (FAC \> 4), regardless of foot-up use
  • Capacity to walk 10m without stopping and repeat the trials 6 times across the session
  • Cognitive ability to understand the study instruction and provide written informed consent

You may not qualify if:

  • clinical instability or acute medical conditions that compromise gait safety
  • concomitant neurological conditions other than stroke
  • severe musculoskeletal disorders that interfere with gait analysis
  • balance or coordination impairments secondary to visual or auditory deficits
  • recent use of substances or medications that impair bait, balance, or postural control
  • pregnancy
  • cognitive or behavioral impairments that prevent the proper performance of the test

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neuron Madrid Río

Madrid, Madrid, 28045, Spain

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Alejandro Herrera Rojas, Physical Therapist

    Neuron, Spain

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physical therapist

Study Record Dates

First Submitted

June 10, 2026

First Posted

June 16, 2026

Study Start

October 10, 2025

Primary Completion

April 20, 2026

Study Completion

May 14, 2026

Last Updated

June 16, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share

Database used for the analyses will be published in zenodo website

Shared Documents
ANALYTIC CODE
Time Frame
Data will be uploaded once analyzed
Access Criteria
Anybody
More information

Locations